ATE292689T1 - Verbesserte verfahren zur transfektion der t- zellen - Google Patents

Verbesserte verfahren zur transfektion der t- zellen

Info

Publication number
ATE292689T1
ATE292689T1 AT96913327T AT96913327T ATE292689T1 AT E292689 T1 ATE292689 T1 AT E292689T1 AT 96913327 T AT96913327 T AT 96913327T AT 96913327 T AT96913327 T AT 96913327T AT E292689 T1 ATE292689 T1 AT E292689T1
Authority
AT
Austria
Prior art keywords
cells
transfection
improved methods
gene
nucleic acid
Prior art date
Application number
AT96913327T
Other languages
English (en)
Inventor
Carl H June
Craig B Thompson
Suil Kim
Original Assignee
Us Navy
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/475,136 external-priority patent/US6692964B1/en
Application filed by Us Navy, Univ Michigan filed Critical Us Navy
Application granted granted Critical
Publication of ATE292689T1 publication Critical patent/ATE292689T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2818—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT96913327T 1995-05-04 1996-05-02 Verbesserte verfahren zur transfektion der t- zellen ATE292689T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43509595A 1995-05-04 1995-05-04
US08/475,136 US6692964B1 (en) 1995-05-04 1995-06-07 Methods for transfecting T cells
PCT/US1996/006200 WO1996034970A1 (en) 1995-05-04 1996-05-02 Improved methods for transfecting t cells

Publications (1)

Publication Number Publication Date
ATE292689T1 true ATE292689T1 (de) 2005-04-15

Family

ID=27030423

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96913327T ATE292689T1 (de) 1995-05-04 1996-05-02 Verbesserte verfahren zur transfektion der t- zellen

Country Status (7)

Country Link
US (1) US20060246587A1 (de)
EP (1) EP0824594B1 (de)
JP (3) JP4031033B2 (de)
AT (1) ATE292689T1 (de)
CA (1) CA2220226C (de)
DE (1) DE69634563T2 (de)
WO (1) WO1996034970A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9907366D0 (en) * 1999-03-30 1999-05-26 Medical Res Council Method for expressing proteins
US7572631B2 (en) 2000-02-24 2009-08-11 Invitrogen Corporation Activation and expansion of T cells
US7541184B2 (en) 2000-02-24 2009-06-02 Invitrogen Corporation Activation and expansion of cells
EP1312670A4 (de) * 2000-08-16 2005-11-30 Takara Bio Inc Methode zur extensiven kultur von antigen-spezifischen cytotoxischen t-zellen
US6627442B1 (en) * 2000-08-31 2003-09-30 Virxsys Corporation Methods for stable transduction of cells with hiv-derived viral vectors
KR100888915B1 (ko) 2001-08-15 2009-03-16 다카라 바이오 가부시키가이샤 항원특이적 세포상해성 ｔ 세포 확대배양방법
JP4406566B2 (ja) 2002-03-25 2010-01-27 タカラバイオ株式会社 細胞傷害性リンパ球の製造方法
KR101331746B1 (ko) 2003-08-22 2013-11-20 다카라 바이오 가부시키가이샤 세포 상해성 림프구의 제조 방법
EP1663308A1 (de) * 2003-09-22 2006-06-07 Xcyte Therapies, Inc Zusammensetzungen und verfahren zur beschleunigung der hämatologischen erholung
WO2006101205A1 (ja) * 2005-03-25 2006-09-28 Kaneka Corporation Ｔ細胞の活性化方法及び活性化ｔ細胞製造用キット
EP1916302A4 (de) 2005-08-17 2009-10-21 Takara Bio Inc Verfahren zur herstellung von lymphozyten
JP5156382B2 (ja) * 2005-09-30 2013-03-06 タカラバイオ株式会社 Ｔ細胞集団の製造方法
JP6754761B2 (ja) * 2014-07-11 2020-09-16 セルジーン コーポレイション Ｔリンパ球へのベクター導入効率の改善方法
CN107980059B (zh) * 2015-04-13 2022-11-11 美克斯细胞有限公司 用于修饰基因组dna的方法和组合物
US10294454B2 (en) 2016-08-24 2019-05-21 General Electric Company Methods and kits for cell activation

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988000970A2 (en) * 1986-08-08 1988-02-11 Regents Of The University Of Minnesota Method of culturing leukocytes
CA2003455C (en) * 1988-11-23 2000-02-22 Craig B. Thompson Immunotherapy involving cd28 stimulation
US5858358A (en) * 1992-04-07 1999-01-12 The United States Of America As Represented By The Secretary Of The Navy Methods for selectively stimulating proliferation of T cells
US5399346A (en) * 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
US5272082A (en) * 1992-03-30 1993-12-21 The Wistar Institute Of Anatomy & Biology Cytotoxic T-ALL cell lines and uses therefor
WO1994012196A1 (en) * 1992-11-25 1994-06-09 Tanox Biosystems, Inc. Conjugates and constructs including anti-cd28 and anti-cd3 binding molecules
KR960701988A (ko) * 1993-04-20 1996-03-28 윌리엄 에스. 로빈슨 세포내 감염원에 감염된 개체의 치료방법 및 치료물질(methods and materials for treatment of individuals infected with intracellular in-fectious agents)
ATE293686T1 (de) * 1993-06-04 2005-05-15 Us Navy Verfahren zur selektiven stimulierung der t- zellproliferation.
FR2707091B1 (fr) * 1993-06-30 1997-04-04 Cohen Haguenauer Odile Vecteur rétroviral pour le transfert et l'expression de gènes dans des cellules eucaryotes.
CA2167091A1 (en) * 1993-07-26 1995-02-02 Gordon J. Freeman B7-2: ctl a4/cd 28 counter receptor
US5733543A (en) * 1994-04-29 1998-03-31 Nabel; Gary J. Introduction of HIV-protective genes into cells by particle-mediated gene transfer
EP0764203A1 (de) * 1994-06-03 1997-03-26 THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE NAVY Verfahren zur selektiven anregung der t-zellproliferation
JPH10501815A (ja) * 1994-06-07 1998-02-17 リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミネソタ 抗原特異的ｔ細胞応答の阻害方法
US6576236B1 (en) * 1994-07-01 2003-06-10 Dana Farber Cancer Institute Methods for stimulating T cell responses by manipulating a common cytokine receptor γ chain
US5795790A (en) * 1994-07-20 1998-08-18 Cytotherapeutics, Inc. Method for controlling proliferation and differentiation of cells encapsulated within bioartificial organs
US5827642A (en) * 1994-08-31 1998-10-27 Fred Hutchinson Cancer Research Center Rapid expansion method ("REM") for in vitro propagation of T lymphocytes
CA2198891A1 (en) * 1994-08-31 1996-03-07 Hartmut Wekerle Genetically modified t cells
US6692964B1 (en) * 1995-05-04 2004-02-17 The United States Of America As Represented By The Secretary Of The Navy Methods for transfecting T cells
US7067318B2 (en) * 1995-06-07 2006-06-27 The Regents Of The University Of Michigan Methods for transfecting T cells

Also Published As

Publication number Publication date
CA2220226A1 (en) 1996-11-07
US20060246587A1 (en) 2006-11-02
WO1996034970A1 (en) 1996-11-07
JP2006109844A (ja) 2006-04-27
DE69634563T2 (de) 2006-02-16
DE69634563D1 (de) 2005-05-12
EP0824594B1 (de) 2005-04-06
JPH11505419A (ja) 1999-05-21
CA2220226C (en) 2008-10-21
JP2007125041A (ja) 2007-05-24
JP4189007B2 (ja) 2008-12-03
EP0824594A1 (de) 1998-02-25
JP4031033B2 (ja) 2008-01-09

Similar Documents

Publication Publication Date Title
EP1586655A3 (de) Verbesserte Methoden zur Transfektion von T Zellen
ATE292689T1 (de) Verbesserte verfahren zur transfektion der t- zellen
ATE124725T1 (de) Verbessertes verfahren zur herstellung von faktor viii:c-typ-proteinen.
DE69736598D1 (de) Ribonukleaseresistente rna präparation und seine verwendung
EP0319944A3 (en) Co-expression in eukaryotic cells
ATE224457T1 (de) Verfahren zur identifizierung von nukleinsäuren, welche agenzien kodieren, die zelluläre phenotypen beeinflussen
DE3785102D1 (de) Verfahren zur herstellung von faktor-viii:c-typ-proteinen.
DE69633669D1 (de) Verfahren zur zelltransfektion mit liposomal-verkapselten nukleinsäuren
ES8700320A1 (es) Metodo de obtencion del exprimido de una materia seleccionada que contiene renina.
DE59510976D1 (de) Verfahren zur isolierung von zellinhaltsstoffen, wie nucleinsäuren, aus natürlichen quellen
ATE391175T1 (de) Multidrug resistenz gen
AU8110487A (en) DNA molecules coding for proteins targeted to plant cell walls
EP0201086A3 (en) Method of producing useful high-molecular-weight substances by culturing proliferous animal cells and culture system therefor
ATE309267T1 (de) Methode zur proliferation und differenzierung von b-zellen und verwendungen dafür
DE3687948D1 (de) Verfahren und nukleinsaeure zur herstellung von lecithin: cholestrinacyltransferase.
FI913266A7 (fi) Menetelmä ulkosyntyisen DNA:n viemiseksi eläinten somaattisten ja itur adan solujen sisään
EP0859059A3 (de) Verfahren und Material zur Einführung von exogen Genen in Zellkulturen oder in fertilisierten Eier
DE69414477D1 (de) Verfahren zur zeitlichen Einteilung von zu Nachrichten gehörenden Zellemissionen sowie Vorrichtung zur Durchführung dieses Verfahrens
CO4790179A1 (es) Procedimiento para la fabricacion de proteinas humanas por activacion genica endogena
DE3579733D1 (de) Verfahren zur trennung von tierischen zellen aus fluessiger kultur.
DK0706567T3 (da) Peptidfamilie betegnet xenoxiner
DE3673686D1 (de) Immobilisierte maltooligosaccharid-bildende amylase und verfahren zur herstellung von maltooligosaccharid unter verwendung des genannten enzyms.
DE69634297D1 (de) Verfahren zur verlängerung der expression eines interessierenden gens unter verwendung von löslichen ctla4 molekülen
DE69616276D1 (de) Verfahren zur produktion von proteinen
IL75118A0 (en) Additives for use in cell culture,culture medium for non-serum cultivation and method of cell culture using them

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0824594

Country of ref document: EP